Results 241 to 250 of about 95,573 (296)
Some of the next articles are maybe not open access.

Collecting Duct Carcinoma

Urologia Internationalis, 2001
Collecting duct carcinoma of the kidney is a rare variant of renal cell carcinoma. Hematuria is the most common presenting symptom. This tubulopapillary tumor arises from or differentiates forward to medullary collecting tubules. It is typically centered on the medulla of the kidney and extends into the cortex with a desmoplastic reaction.
, Tulunay O   +5 more
openaire   +2 more sources

Collecting Duct Carcinoma

2018
Collecting duct carcinoma (CDC) of the kidney is a rare variant of renal cell carcinoma (RCC) with an extremely poor prognosis as most cases are metastatic at the time of diagnosis. RCC is a clinically, histologically and genetically heterogeneous group of tumours.
Hendrik Van Poppel   +6 more
  +4 more sources

Comparative analyses of tumour immune microenvironment between collecting duct carcinoma and fumarate hydratase-deficient renal cell carcinoma

Journal of Clinical Pathology, 2022
Aims Collecting duct carcinoma (CDC) and fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) have similar histological morphologies and both show a poor prognosis.
Daisuke Kiyozawa   +10 more
semanticscholar   +1 more source

Cortically located collecting duct carcinoma

Urology, 2005
Collecting duct carcinoma is a rare, highly aggressive, renal tumor arising from the distal collecting ducts. Various histologic patterns can be found in the same tumor but most demonstrate duct-like or papillary architecture surrounded by desmoplastic stroma.
Sozen, S   +4 more
openaire   +3 more sources

Abstract 1123: Comprehensive molecular characterization reveals hallmarks and therapeutic insights of collecting duct carcinoma

Cancer Research
Collecting duct carcinoma (CDC) is a rare and aggressive subtype of renal carcinoma, posing significant challenges in diagnosis and treatment. Current treatment relies on platinum-based chemotherapy, yet clinical outcomes remain poor.
Xiaofan Lu   +7 more
semanticscholar   +1 more source

Collecting Duct Carcinoma

Scandinavian Journal of Urology and Nephrology, 1996
Collecting duct carcinoma is a rare form of renal tumour. Its recognition is important both clinically and histopathologically since it can mimic other renal neoplasms in appearance. Nephrectomy is the treatment of choice and, as the tumour usually pursues an aggressive course, adjuvant chemotherapy or immunotherapy may also be considered appropriate ...
A L, Armstrong, B R, Birch, J, Cumming
openaire   +2 more sources

68Ga-Pentixafor Uptake in Collecting Duct Carcinoma.

Clinical Nuclear Medicine
Collecting duct carcinoma (CDC), also known as Bellini duct carcinoma, is a highly aggressive and extremely rare subtype of renal cell carcinoma. Previous studies have suggested that CDC generally exhibits low CXCR4 expression, leading to negative or ...
Juan Yang   +4 more
semanticscholar   +1 more source

Collecting Duct Carcinoma

2005
Collecting duct carcinoma is an aggressive subtype of RCC derived from the renal medulla. The tumor occurs in a wide age range, predominately in men. The usual histologic pattern is that of a tubular or tubulopapillary carcinoma with a desmoplastic stroma.
Seong Kuk Yoon, Seo Hee Rha
openaire   +1 more source

Collecting duct carcinoma: cytogenetic characterization

Histopathology, 1992
Most renal cell carcinomas are assigned to either the papillary or clear cell, non‐papillary type by morphological and cytogenetic criteria. In rare cases, papillary carcinomas of the kidney have been classified as collecting duct carcinoma because of their medullary localization and the associated hyperplastic and dysplastic epithelial lesions of ...
L, Füzesi, M, Cober, C, Mittermayer
openaire   +2 more sources

Collecting duct renal cell carcinoma

Actas Urológicas Españolas (English Edition), 2011
Bellini's renal cell collecting duct carcinoma is a rarely prevalent renal tumour, with low cancer-specific survival, although its rate of response to antiangiogenic therapies is unknown.We retrospectively revise a series of collecting duct tumours, with special emphasis on the indication of target therapies and on their results.Retrospective analysis ...
A, Husillos   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy